Tag: FDA Safety Alert

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

Some FDA-recalled medical devices remain in use while manufacturers implement corrections

Editor's Note A 2016 recall issued for the Abbott MitraClip cardiac device highlighted potential safety concerns, but instead of removing the product from the market, Abbott and the Food and Drug Administration (FDA) allowed continued use with revised instructions and additional training for doctors. This approach reflects a broader trend…

Read More

By: Tarsilla Moura
August 27, 2024
Share

FDA warns healthcare providers to conserve blood culture media bottles amid shortage

Editor's Note Healthcare providers should consider strategies to conserve BD BACTEC blood culture media bottles for patients at highest risk due to an ongoing shortage, according to a July 10 report from The US Food and Drug Administration (FDA). Attributing the shortage to supplier issues, FDA warns that the disruption…

Read More

By: Matt Danford
July 29, 2024
Share

FDA warns of continued cardiac pump safety concerns after series of recalls

Editor's Note The US Food and Drug Administration (FDA) is urging healthcare providers to avoid using Getinge heart devices due to continued safety concerns that remain unaddressed despite previous recalls. Issued to healthcare providers May 8, the warning letter applies to Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices…

Read More

By: Matt Danford
May 9, 2024
Share

Joint replacement manufacturer recalls products after FDA packaging warning

Editor's Note A January complaint about inefficient packaging for joint replacement products has prompted the manufacturer to recall certain knee and shoulder system devices after initially declining to take the products off the market, according to an April 23 report in Health Exec. The manufacturer, Exactech, is now recalling a…

Read More

By: Matt Danford
April 25, 2024
Share

FDA updates warning about plastic syringes made in China

Editor's Note An ongoing US Food and Drug Administration (FDA) evaluation of plastic syringes made in China reveals that quality problems are more widespread than initially believed, the agency reported on March 19. The update to an original November 23 safety notice recommends the following action to alleviate potential quality…

Read More

By: Matt Danford
March 20, 2024
Share

FDA issues warning on fraudulent, unreliable medical device testing data

Editor's Note The FDA has issued a warning regarding fraudulent, duplicated and otherwise unreliable data coming from third party test labs that produce data for medical device companies, including many based in India and China. Issued February 20, the alert warns medical device manufacturers that they are responsible for confirming the…

Read More

By: Brita Belli
February 21, 2024
Share

FDA updates safety recall of certain saline, sterile water medical products

Editor's Note The US Food and Drug Administration (FDA) on January 24 updated its safety recall communication from November 6 to add to the voluntary recalls of saline and sterile water medical products associated with Nurse Assist, LLC. The FDA recall notice lists various water-based medical products manufactured by Nurse…

Read More

By: Tarsilla Moura
January 31, 2024
Share

FDA safety alert targets shoulder implant packaging

Editor's Note: Equinoxe Shoulder System joint replacement devices manufactured by Exactech between 2004 and 2021 are at risk of premature wearing or failure due to defective packaging, according to a January 16 safety alert from the US Food and Drug Administration (FDA). The bags used to package the devices were…

Read More

By: Matt Danford
January 23, 2024
Share

Superpotency concerns spur recall of IV bags for vancomycin, phenylephrine, and fentanyl

Editor's Note:  Englewood, Colo,-based Leiters Health is voluntarily recalling 33 lots of vancomycin, phenylephrine, and fentanyl IV bags due to concerns that they may contain twice the labeled amount of drug, according to a January 8 safety alert from the US Food and Drug Administration (FDA). “The semi-automated IV bag…

Read More

By: Matt Danford
January 11, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat